CF Foundation Launches Fully Redesigned Website to Meet the Evolving Needs of People with CF and their Families

Cystic Fibrosis Foundation
Posted on: 21 Jul 15
Today, the Cystic Fibrosis Foundation announced the launch of its fully redesigned website, www.cff.org. The new site reflects the Foundation’s ongoing commitment to provide people with CF the support, tools and information they need to live long and Continue reading CF Foundation Launches Fully Redesigned Website to Meet the Evolving Needs of People with CF and their Families

Doctors challenge Vertex over high price of cystic fibrosis drug

Originally published in the Boston Globe: https://www.bostonglobe.com/business/2015/07/20/researcher-and-group-doctors-challenge-vertex-price-new-cystic-fibrosis-drug/d5PZMlj6T6uzq0usm2xLEL/story.html#

By Globe Staff 

California scientist Paul M. Quinton learned that he has cystic fibrosis at age 19 and has spent his long career in his lab working on ways to cure it. Continue reading Doctors challenge Vertex over high price of cystic fibrosis drug

Vertex Should Expect Approvals For Its Cystic Fibrosis Medications

Summary
• The FDA should see a favorable benefit-to-risk ratio for KALYDECO in children of ages 2-5.
• Positive Phase 3 trials in patients with the most common CF mutation should also be enough for approval. This will triple the current addressable CF market. Continue reading Vertex Should Expect Approvals For Its Cystic Fibrosis Medications

Clinical Trial Alert Vertex Pharmaceuticals

Phase 3 Trial with VX-661 and VX-770 in CF Patients Homozygous DeltaF508 Now Enrolling!

CFF info about this study: http://www.cff.org/Display/dsp_ClinicalResearchHTML.cfm?id=402&CTSubId=79 Continue reading Clinical Trial Alert Vertex Pharmaceuticals